Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Gritstone bio
Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update
November 11, 2024
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTSQ
Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer
September 30, 2024
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 13, 2024
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
May 09, 2024
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite
April 01, 2024
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
March 05, 2024
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 08, 2023
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 Vaccine
October 11, 2023
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million
September 27, 2023
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
August 09, 2023
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 11, 2023
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
March 09, 2023
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update
November 03, 2022
From
Gritstone bio
Via
GlobeNewswire
Tickers
GRTS
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.